The relationship between atherosclerosis and venous thromboembolism (VTE) is controversial. In total, 10 426 participants recruited from the general population were included. Carotid intima media thickness and total plaque area was not associated with VTE. There was no association between plaque initiation or plaque progression and subsequent VTE.
Introduction
Although medical textbooks consider venous thromboembolism (VTE) and arterial cardiovascular disease as different disease entities [1] , Virchow's triad (1856) postulates that the pathophysiology of thrombosis, either venous or arterial, is an interplay between: (i) stasis of the blood; (ii) hypercoagulability; and (iii) vessel wall injury [2] . The vascular component of Virchow's triad has been much less studied in the etiology of VTE than in that of arterial cardiovascular disease, for which vessel wall injury is an established precursor of disease.
Interestingly, recent studies have shown that arterial cardiovascular diseases, such as myocardial infarction and ischemic stroke, are associated with an increased risk of VTE [3] [4] [5] . In addition, in a landmark study from 2003, Prandoni et al. reported that atherosclerosis, measured according to total plaque area (TPA), was twice as prevalent in patients with unprovoked venous thrombosis as in age-matched and sex-matched controls [6] . These findings suggested that atherosclerosis could be a shared risk factor for arterial cardiovascular disease and VTE. Although the association between atherosclerosis and arterial cardiovascular disease is well established [7] [8] [9] , the association between atherosclerosis and VTE remains controversial. For instance, case-control studies are not designed to reveal the direction of the association, and do not enable interpretations on causality, owing to the undetermined temporal sequence between exposure and outcome. Furthermore, the association between atherosclerosis and VTE might be explained by the presence of confounding risk factors, such as increasing age and obesity [10] .
Previous cohort studies did not show any association between atherosclerosis and subsequent VTE [11] [12] [13] . However, these cohorts were based on a single measurement of TPA and carotid intima media thickness (IMT) obtained at the beginning of a follow-up period that lasted for > 10 years. Because atherosclerosis may develop over time, a long follow-up with several years between the baseline measurement and the event could introduce regression dilution bias, and thereby lead to underestimation of the true association [14, 15] . Therefore, a small effect of atherosclerosis on VTE risk could be masked in traditional cohort studies with single measurements and long-term follow-up. The potential problem of regression dilution could be overcome by utilizing repeated assessments of the atherosclerosis status within the same individuals during follow-up. This will provide a more accurate estimation of the risk status at the time before the outcome occurs.
We therefore aimed to investigate the association between the presence, formation and progression of carotid atherosclerosis and VTE by using a large prospective cohort with repeated measurements of IMT and TPA, in participants recruited from the general population.
Methods

Study population
Participants were recruited from the fourth, fifth and sixth surveys of the Tromsø Study, conducted in 1994-1995, 2001-2002, and 2007-2008 , respectively. In the fourth study, all inhabitants aged 55-74 years and a random 5-10% sample in the other age groups > 24 years, were invited to a second, more extensive examination, including ultrasonography of the carotid artery [16] . Subjects who attended the second visit of Tromsø 4, in addition to random samples within different age groups, were eligible for the second visit of Tromsø 5 and for Tromsø 6. A detailed description of the Tromsø Study has been published elsewhere [17] . Participants with a previous history of VTE were excluded. In addition, participants attending for the ultrasound examination, but with missing information on the measures of carotid atherosclerosis, were excluded. In total, 10 426 participants attended for ultrasound examination of the right carotid artery in Tromsø 4, 5, and/or 6 ( Fig. 1) . The study was approved by the regional committee for research ethics in North Norway, and all participants gave their informed, written consent.
Atherosclerotic risk factors and assessment of atherosclerosis
Information on atherosclerotic risk factors was collected by physical examination, blood sampling, and self-administered questionnaires, and the collection was repeated at each survey. Height, weight, blood pressure and non-fasting serum lipids were measured as previously described in detail [18] . Body mass index (BMI) was calculated as weight in kilograms divided by the square of height in meters (kg m À2 ). Questionnaires were used to obtain information on the use of lipid-lowering drugs, current smoking, diabetes mellitus, physical activity, and education. Ultrasound examination of the right carotid artery was performed for assessment of IMT and TPA. A thorough description of the ultrasound examination has been published previously [16, [19] [20] [21] . In brief, high-resolution In each subject, a maximum of six plaques were registered in the near and far walls of the distal part of the common carotid artery (CCA), bifurcation, and ICA, respectively. TPA was calculated as the sum of all plaques. IMT was defined as the average of the mean IMT values of the near and far walls of the CCA and the far wall of the bifurcation. To minimize variability in IMT during the cardiac cycle, image capture was standardized by recording images at the top of the R-wave in an electrocardiogram (ECG) signal. Plaque initiation was defined as the development of new plaques at follow-up in vessels without plaques at the previous examination, and plaque progression was defined as the difference in TPA between two measurements. Participants with negative progression were included in the no-progression group [16, 22] .
Identification and validation of VTE
All incident VTE events during follow-up were identified by searching the hospital discharge diagnosis registry, the autopsy registry and the radiology procedure registry at the University Hospital of North Norway. The University Hospital of North Norway is the only hospital in the region, and all diagnostic radiology and hospital care is provided exclusively by this hospital. The medical record for each potential case of VTE was reviewed by trained personnel, and a VTE event was considered to be adjudicated when the presence of clinical signs and symptoms of deep vein thrombosis (DVT) or pulmonary embolism was combined with objective confirmation tests (by compression ultrasonography, venography, spiral computed tomography, perfusion-ventilation scan, pulmonary angiography, and autopsy), and resulted in a VTE diagnosis that required treatment, as previously described in detail [23] . DVTs were recorded in the upper and lower extremities, including the inferior vena cava, and at unusual sites (the mesenteric veins, portal veins, and in the venous sinuses). VTE cases from the autopsy registry were recorded when the death certificate indicated VTE as the cause of death or as a significant condition contributing to death.
Statistical analysis
Statistical analyses were performed with STATA version 14.0 (Stata Corporation, College Station, TX, USA). As the distribution of TPA was skewed to the right, TPA was square root transformed to approximate a normal distribution for the analyses in which TPA was used as a continuous variable. Cox proportional hazard regression models were used to assess the association between atherosclerosis (i.e. IMT and TPA) and VTE in a time-varying analysis. In these analyses, all participants contributed with one or more observation periods, each lasting from one measurement until the next, or until a censoring event (i.e. migration, death, or end of study period) occurred. The follow-up ended on 31 December 2012. Atherosclerosis measurements and other risk factors were updated at every survey, when available, and used as time-varying covariates. Of the 10 426 participants included in the study, 5154 participants attended two or three surveys, which resulted in a total number of 18 154 observation periods for the time-varying analyses. For participants attending only one survey, measurements were valid from baseline to the first censoring event. Age was used as the time-scale, with the participants' age at study enrolment being defined as entry time, and age at the censoring event being defined as exit time. Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated, and all analyses were adjusted for age (as timescale), sex, and BMI. The proportional hazards assumption was confirmed with Schoenfeld's global test. Statistical interactions between the covariates and the main exposures were tested by including the cross-product terms in the proportional hazard model, and no interactions were found.
We performed two sensitivity analyses. In the first sensitivity analysis, we censored participants at the next survey that they did not attend. This analysis was performed to ensure that the carry-on of measurements in participants who attended only one survey did not dilute the effect in the original analyses. Statin use may potentially confound the association between atherosclerosis and VTE. As we did not have sufficient information on statin use among the Tromsø 4 participants, the second sensitivity analysis was restricted to participants who did not use lipid-lowering drugs in Tromsø 5 or Tromsø 6.
Results
During a median follow-up of 10.8 years, 368 participants experienced an incident VTE event. The baseline characteristics of traditional atherosclerotic risk factors and TPA across quartiles of carotid IMT are shown in Table 1 . In general, all traditional atherosclerotic risk factors changed for the worse across increasing quartiles of IMT. Participants in the fourth quartile had higher blood pressure, BMI, triglyceride levels, and total cholesterol levels, and lower HDL cholesterol levels, than participants in the first quartile. Among participants in the highest quartile, there were also higher proportions of males and of participants with hypertension and self-reported diabetes, and a lower proportion of physically active and highly educated participants. The quartiles of IMT contained approximately the same proportions of current smokers.
HRs for VTE with TPA and IMT as continuous and categorical variables are shown in Table 2 . There was no association between TPA as a continuous variable and VTE (HR per standard deviation [SD] increase of 0.99, 95% CI 0.90-1.11), and no linear trend of increased risk of VTE across increasing tertiles of TPA when no plaque was set as the reference group (P for trend = 0.9). IMT was not associated with risk of VTE (HR per SD increase of 0.96, 95% CI 0.86-1.07), and the P for trend across increasing quartiles of IMT was 0.7. Additional adjustment for total cholesterol, HDL cholesterol, smoking, diabetes mellitus and diastolic blood pressure had a negligible effect on the risk estimates (HRs per SD increase for TPA and IMT were 0.98 [95% CI 0.88-1.09] and 0.96 [95% CI 0.86-1.07], respectively). Similar results were obtained when the participants were censored at the first survey that they did not attend (Table S1 ) and when the analyses were restricted to participants not using lipidlowering drugs in Tromsø 5 or 6 (Table S2) .
HRs for VTE according to the formation and progression of carotid plaques are shownd in Table 3 . There was no association between plaque formation and future risk of VTE (HR 1.00, 95% CI 0.98-1.02). Progression of carotid plaque size was not associated with VTE (HR 0.96, 95% CI 0.84-1.11), and there was no linear trend of VTE risk across tertiles of plaque progression in TPA (P for trend = 0.5). The multivariable-adjusted model showed similar results for both plaque formation and plaque progression.
Discussion
Previous case-control studies have reported an association between carotid plaques and VTE [6, 24] , whereas later cohort studies [11] [12] [13] have not shown any association between carotid atherosclerosis and future risk of VTE. A potential limitation of cohorts with long followup is that changes in atherosclerosis over time could lead to an underestimation of the true association between atherosclerosis and VTE [14, 15] . To investigate whether the apparent discrepancy in results in case-control and cohort studies could be explained by regression dilution bias, we conducted a study with repeated measurements of carotid atherosclerosis within the same individuals BP, blood pressure; BMI, body mass index; SD, standard deviation; VTE, venous thromboembolism. *Hypertension: systolic BP of ≥ 140 mmHg, or diastolic BP of ≥ 90 mmHg, or the use of antihypertensive medicine. †Hard physical activity for ≥ 1 h every week. ‡Fifteen or more years of education (corresponding to 3 years in a university or academy). with negative change were included in the no progression group. §Adjusted for age (as time scale), sex and BMI. ¶Adjusted for age (as time scale), sex, BMI, total cholesterol, high-density lipoprotein cholesterol, smoking, diabetes mellitus and diastolic blood pressure.
during follow-up. We found that measures of carotid atherosclerosis were not associated with future risk of VTE. Our findings suggest that atherosclerosis as measured with carotid ultrasonography is not an intermediate for the association between arterial and venous thrombosis. Our results are in accordance with those of previous cohort studies on the association between atherosclerosis and VTE using time-fixed analyses [11] [12] [13] . The Atherosclerosis Risk in Communities study, which included 13 000 subjects aged 45-64 years with a median follow-up time of 12.5 years, found no association between increased carotid IMT or the presence of carotid plaques and VTE risk [11] . The Cardiovascular Health Study study followed 4100 subjects aged ≥ 65 years for a period of 12 years, and measured subclinical atherosclerosis according to IMT, the presence of carotid plaques, ankle brachial index, and ECG abnormalities. In this study, subclinical atherosclerosis was not associated with an increased risk of overall or unprovoked VTE. Unexpectedly, they found an inverse relationship between high-risk carotid plaques and VTE [12] . Furthermore, a previous study from the Tromsø cohort with 15.4 years of follow-up, including > 6200 participants, found that single measurements of IMT and TPA at baseline were associated with future myocardial infarction, but not VTE [13] .
The finding of no association between atherosclerosis and VTE in cohort studies is in contrast to the results from two previous case-control studies [6, 24] . Prandoni et al. reported a higher frequency of carotid plaques in 153 patients with unprovoked VTE than in 146 patients with provoked VTE and 150 hospitalized controls. In this study, plaques were defined as a protrusion into the vessel lumen of at least 2 mm [6] . In a study including 89 cases of unprovoked VTE and 89 controls, Hong et al. reported an association between coronary artery calcification and VTE [22] . Several factors may explain the divergent results between cohort and case-control studies conducted on this topic. Recruitment of controls that are not fully representative of the source population from which the cases were derived may result in overestimation of the true effect in case-control studies. This problem is more likely to occur when the size of the control group is small. Moreover, the exposure is measured after the outcome in case-control studies, and therefore the temporal sequence of the events cannot be determined. In conventional cohorts, exposure may change over time, and this may lead to underestimation of the true effect. However, with repeated measurements, it was possible to update an individual's risk status over time, and consequently obtain a better estimation of an individual's atherosclerotic status in the period before the VTE diagnosis. Using this approach, we did not find any association between carotid atherosclerosis measures and VTE risk.
Although some studies have reported associations between atherosclerotic risk factors, such as diabetes, hypertension, and dyslipidemia, and the risk of VTE [25] [26] [27] , the only atherosclerotic risk factors that have consistently been shown to increase the risk of VTE are age and obesity [18, 28, 29] . A recent meta-analysis of nine cohorts, including almost 250 000 participants and 5000 VTEs, found no association between traditional, modifiable atherosclerotic risk factors and VTE, using traditional time-fixed Cox regression models adjusted for age, sex, and BMI [30] . The only exception was cigarette smoking, which was associated with an increased risk of provoked VTE, an association that was possibly mediated through other conditions such as cancer. Furthermore, in a previous report from the Tromsø Study, based on repeated measurements of atherosclerotic risk factors, we showed that BMI, but not blood pressure, serum lipid levels, diabetes, or smoking, was associated with an increased risk of VTE [31] .
Major strengths of our study include the prospective design with repeated exposure measurements and long follow-up, the large number of participants recruited from the general population, and the thorough validation and adjudication of VTE. The repeated measurements of atherosclerosis and potential confounders made it possible to update risk status over time, and thereby to reduce the chance of regression dilution bias. The study has some limitations. Unfortunately, we did not have verified baseline information on previous history of VTE among all of the study subjects. We started to identify VTE cases in January 1994, and those who were registered with a recurrent event in the study period (1994-2012), and those who had a VTE shortly before inclusion, were identified and excluded from the analyses because of previous VTE. Subjects who had a VTE before 1994 and did not experience a recurrence in the study period would not be detected, and, consequently, these would be treated as healthy participants during follow-up. As the prevalence of VTE in the general population is relatively low, this would lead to only a small change in the overall number of person-years at risk, and thus would presumably have a negligible influence on the risk estimates. Carotid ultrasonography is operator-dependent and prone to measurement errors. However, a previous study found the overall reproducibility of TPA to be good, with small interobserver mean arithmetic and mean absolute differences [16] . Although the measurement errors in carotid ultrasonography are too large to allow study of the progression of atherosclerosis at an individual level, carotid ultrasonography at a population level gives enough power to overcome the measurement variability, and makes it possible to detect even weak associations [16] . Examination of only one carotid artery may potentially introduce misclassification. However, studies comparing ultrasound IMT measurements of the left and right common carotid artery found no significant difference between the sides in the normal population [32, 33] . Furthermore, studies have shown that carotid atherosclerosis correlates well with the general extent of atherosclerotic disease in an individual [34, 35] . Statins have been shown to reduce the risk of VTE in some [36] [37] [38] , but not all, studies [39, 40] . Statin use reduces carotid plaque development and lowers plaque progression [41, 42] , and lack of adjustment for statin use could result in underestimation of the association between atherosclerosis and VTE. However, sensitivity analysis restricted to participants who did not use statins showed no association between carotid atherosclerosis and VTE. Aspirin is often prescribed to subjects at risk of cardiovascular disease, but may also prevent venous thrombosis. However, although aspirin use has been associated with a decreased risk of recurrent VTE [43, 44] , it has not been associated with a reduced risk of incident VTE in population-based studies [37, 45] .
In conclusion, we found that the formation and progression of carotid atherosclerosis, as measured with ultrasonography, was not associated with future risk of VTE in time-varying analyses. Our findings suggest that atherosclerosis is not an intermediate for the association between arterial cardiovascular diseases and VTE. 
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